Sexual dysfunction in male patients with hypertension: Influence of antihypertensive drugs

Drugs

Volumn 65, Issue 6, 2005, Pages 773-786

  Düsing, Rainer ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CHLORTALIDONE; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; GUANETHIDINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; METHYLDOPA; PLACEBO; PRAZOSIN; PROPRANOLOL; RESERPINE; THIAZIDE DIURETIC AGENT; VALSARTAN;

ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CORRELATION ANALYSIS; DIABETES MELLITUS; DOSE RESPONSE; ERECTILE DYSFUNCTION; HEALTH SURVEY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPOTENCE; INCIDENCE; LIBIDO DISORDER; PREVALENCE; QUESTIONNAIRE; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL INTERCOURSE;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; MALE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 17844396904     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200565060-00005     Document Type: Review

References (75)

1. Chobanian AV, Bakris GL, Black HR, et al., on behalf of the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-52
2. Staessen JA, Wang J. Blood pressure lowering for the secondary prevention of stroke. Lancet 2001; 358; 1026-7
3. Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial. Am J Epidemiol 2001; 153: 72-8
4. Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998; 51: 986-93
5. Glynn RJ, Beckett LA, Hebert LE, et al. Current and remote blood pressure and cognitive decline. JAMA 1999; 281: 438-45
6. Sacktor N, Gray S, Kawas C, et al. Systolic blood pressure within an intermediate range may reduce memory loss in an elderly hypertensive cohort. J Geriatr Psychiatry Neurol 1999; 12: 1-6
7. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001; 56: 1683-9
8. Feldmann HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61
9. Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003; 139: 161-8
10. Düsing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Pressure 2003; 12 Suppl. 2: 29-34
11. Fogari R, Zoppi A. Effect of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Report 2002; 4: 202-10
12. NIH Consensus Development Panel on Impotence. Impotence. JAMA 1993; 270: 83-90
13. Kinsey AC, Pomeroy W, Martin CE. Age and sexual outlet. In: Kinsey AC, Pomeroy W, Martin CE, editors. Sexual behaviour in the human man. Philadelphia (PA): WB Saunders, 1948: 218-62
14. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impotence Res 2000; 12: 305-11
15. Blanker MH, Bosch JL, Groeneveld FP, et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50-78 years old: prevalence, concern, and relation to sexual activity. Urology 2001; 57: 763-8
16. Ansong KS, Lewis C, Jenkins P, et al. Epidemiology of erectile dysfunction: a community-based study in rural New York. Ann Epidemiol 2000; 10: 293-6
17. Parazzini F, Menchini Fabris F, Bortolotti A, et al. Frequency and determinants of erectile dysfunction in Italy. Eur J Urol 2000; 37: 43-9
18. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206
19. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13
20. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997; 96: 308-15
21. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 21: 1011-1053
22. World Health Organization(WHO)/International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension statement on management of hypertension. J Hypertens 2003; 21: 1983-92
23. Grimm RH Jr, Grandits GA, Prineas RJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29: 8-14
24. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328: 914-21
25. Della Chiesa A, Pfifner D, Meier B, et al. Sexual activity in hypertensive men. J Human Hypertens 2003; 17: 515-21
26. Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001; 14: 27-31
27. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-38
28. Madersbacher S, Temmel C, Racz U, et al. Prevalence and risk factors for erectile dysfunction in Austria: analysis of a health screening project. Wien Klin Wochenschr 2003; 115: 822-30
29. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30
30. Akkus E, Kodioglu A, Esen A, et al., on behalf of the Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002; 41: 298-304
31. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina Study. J Urol 2001; 166: 569-74
32. Naya Y, Mizutani Y, Ochiai A, et al. Preliminary report of association of chronic diseases and erectile dysfunction in middle-aged men in Japan. Urology 2003; 62: 532-6
33. Seyram RM, Albakry A, Ghobish A, et al. Prevalence of erectile dysfunction and its correlates in Egypt: a community-based study. Int J Impot Res 2003; 15: 237-45
34. Berrada S, Kadri N, Mechakra-Tahiri S, et al. Prevalence of erectile dysfunction and its correlates: a population-based study in Morocco. Int J Impot Res 2003; 15 Suppl. 1: S3-7
35. Walczak MK, Lokhandwala N, Hodge MB, et al. Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002; 5: 19-24
36. Müller SC, el-Damanhoury H, Ruth J, et al. Hypertension and impotence. Eur Urol 1991; 19: 29-34
37. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181-4
38. Aranda P, Ruilope LM, Calvo C, et al., on behalf of the Sildenafil Study Group. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. Am J Hypertens 2004; 17: 139-45
39. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of the International Index of Erectile Function (11EF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-26
40. Bansal S. Sexual dysfunction in hypertensive men: a critical review of the literature. Hypertension 1988; 12: 1-10
41. Bulpitt CJ, Dollery CT, Carne S. Changes in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121-8
42. Bauer GE, Hunyor SN, Baker J, et al. Clinical side effects during antihypertensive therapy: a placebo-controlled double-blind study. Postgrad Med Comm 1981; (Special Report): 49-54
43. Croog SH, Levine S, Sudilovsky A, et al. Sexual symptoms in hypertensive patients: a clinical trial of antihypertensive medications. Arch Intern Med 1988; 148: 788-94
44. Fogari R, Zoppi A, Preti P, et al. Sexual activity and plasma testosterone levels in hypertensive males. Am J Hypertens 2002; 15: 217-21
45. Veterans Administration Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: III. Influence of age, diastolic pressure, and prior cardiovascular disease: further analysis of side effects. Circulation 1972; 45: 991-1004
46. Perry Jr HM. Treatment of mild hypertension: preliminary results of a two-year feasibility trial. Circ Res 1977; 40 Suppl. 1: 1180-7
47. Bulpitt CJ, Dollery CT. Side effects of hypotensive agents evaluated by a self-administered questionnaire. BMJ 1973; 3: 485-90
48. Newman RJ, Salerno HR. Sexual dysfunction due to methyldopa [letter]. BMJ 1974; 4: 106
49. Kolodny RC. Effects of α-methyldopa on male sexual function. Sexuality and Disability 1987; 1: 223-7
50. Rosen RC, Kostis JB, Jeckelis A, et al. Sexual sequelae of antihypertensive drugs: treatment effects on self report and physiological measures in middle-aged male hypertensives. Arch Sex Behav 1994; 23: 135-52
51. Saunders E, Kong WB. Sexual activity in male hypertensive patients while taking clonidine. Urban Health 1980; 9: 26
52. Hogan MJ, Wallin JD, Baer RM. Antihypertensive therapy and male sexual dysfunction. Psychosomatics 1981; 21: 234-7
53. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for treatment of mild hypertension. Lancet 1981; 2: 539-43
54. Wassertheil-Smoller S, Blaufox MD, Oberman A, et al. Effects of antihypertensives on sexual function and quality of life: the TAIM Study. The TAIM Research Group. Ann Intern Med 1991; 114: 613-20
55. Stessman J, Ben-Ishay D. Chlorthalidone-induced impotence. BMJ 1980; 281: 714
56. Chang SW, Fine R, Siegel D, et al. The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991; 151: 2402-8
57. Fogari R, Zoppi A, Corradi L, et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 1998; 11: 1244-7
58. Fogari R, Preti P, Derosa G, et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002; 58: 177-80
59. Fletcher AE, Chester PC, Hawkins CMA, et al. The effects of verapamil and propranolol on quality of life in hypertension. J Hum Hypertens 1989; 3: 125-30
60. Suzuki H, Tominaga T, Kumagai H, et al. Effects of first-line antihypertensive agents on sexual function and sex hormones. J Hypertens 1988; 6 Suppl. 4: S649-51
61. Rosen RC, Kostis JB, Jekelis AW. Beta-blocker effects on sexual function in normal males. Arch Sex Behav 1988; 17: 241-55
62. Kostis JB, Rosen RC, Holzer BC, et al. CNS effects of centrally active antihypertensive agents: a prospective placebo-controlled study of sleep, mood-state, cognitive and sexual function in hypertensive males. Psychopharmacology 1990; 102: 163-70
63. Silvestri A, Galetta P, Cerquetani E, et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 2003; 24: 1928-32
64. Kroner BA, Mulligan T, Briggs GC. Effect of frequently prescribed cardiovascular medications on sexual function: a pilot study. Ann Pharmacother 1993; 27: 1329-32
65. Omvik P, Thaulow E, Herland OB, et al. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study. J Hypertens 1993; 11: 103-13
66. Llisterri Caro JL, Lozano Vidal JV, Aznar Vicente J, et al. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001; 321: 336-41
67. Fogari R, Preti P, Mugellini A, et al. Different effect of valsartan and lisinopril on sildenafil use in hypertensive men with erectile dysfunction [abstract]. Am J Hypertens 2002; 15: 37A
68. Fogari R, Preti P, Zoppi A, et al. Effect of valsartan and atenolol on sexual behaviour in hypertensive postmenopausal women. Am J Hypertens 2004; 17: 77-81
69. Düsing R, Lottermoser K, Mengden T. Compliance with drug therapy: new answers to an old question. Nephrol Dial Transplant 2001; 16: 1317-21
70. Düsing R. Adverse events, compliance, and changes in therapy. Curr Hypertens Rep 2001; 3: 488-92
71. Caro JJ, Speckmann JL, Salas M, et al. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ 1999; 160: 41-6
72. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20: 671-81
73. Conlin PR, Gerth W, Fox J, et al. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan vs. other antihypertensive drug classes. Clin Ther 2001; 23: 1999-2010
74. Monane M, Bohn RL, Gurwitz JH, et al. The effect of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697-704
75. Unger T. The ongoing telmisartan alone and in combination with ramipril global endpoint trial program. Am J Cardiol 2003; 91: 28G-34G